@alexlac51 Aye, who'd have thought "the details guy" has no feckin clue about the details.
#SlipperySunak

So how has #SlipperySunak performed against his 5 pledges that quickly morphed into 5 promises.

I’ll let you take a more detailed look yourself but spoiler alert it’s mostly been a total fail!

#GTTO #GeneralElectionNow

https://www.bestforbritain.org/rishis_pledges

Rishi's Five Pledges

Best for Britain

#SlipperySunak says he hasn’t read the Privileges Committee Report and gives the weakest of weak excuses for his failure to attend Parliament when quizzed by Chris Bryant at the Liaison Committee.

Absolutely pathetic #GTTONow #GeneralElectionNow

https://news.sky.com/story/politics-latest-chancellor-to-meet-regulators-in-bid-to-tackle-cost-of-living-another-minister-pauses-support-for-korski-12593360

Politics latest: Sunak draws gasps after admitting he hasn't read three-page report; MP to stand down over 'toxic' Westminster environment

Rishi Sunak faced questions on cost of living pressures and the state of public services as he came under scrutiny from senior MPs on the Liaison Committee. Meanwhile, the SNP's deputy leader in the Commons has said she will step down at the next general election.

Sky News
Record profits for firm involved in bungled £250m PPE deal

Exclusive: Ayanda Capital’s earnings rise by 2,600% after winning huge COVID contract – but masks were rejected by NHS

openDemocracy

“The truth with this trust is that the only people that are blind to it are the public. Rishi Sunak only set up the trust in 2019 but the public has no idea where the money is or whether there is a conflict of interest. With public trust in this government plummeting, greater transparency in all their dealings is essential and Rishi Sunak must show a lead."

Ed Davey,
Liberal Democrat M.P.
U.K.

#UKPolitics
#SlipperySunak

https://www.theguardian.com/politics/2020/nov/17/rishi-sunak-refuses-to-say-if-he-will-profit-from-moderna-covid-vaccine

Rishi Sunak refuses to say if he will profit from Moderna Covid vaccine

Chancellor’s hedge fund invested heavily in Moderna, which had 94.5% trial success

The Guardian